SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 7.96.
| Share Price | ₹377.3 | Jan 29,2026 |
| Market Cap | ₹14,433.6 Cr | |
| Sales-TTM | ₹1,814.1 Cr | TTM-Consolidated Results |
| Price/Sales | 7.96x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹14,433.6 Cr] as on Jan 29,2026
(/) Sales [ ₹1,814.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.96x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '7.96 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.89x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 12.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 24.66x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 8.98x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN PHARMACEUTICALS | 1,814.1 | 7.96 | 14,433.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 6.94 | 381,326.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.98 | 160,299.0 |
| CIPLA LTD | 28,351.1 | 3.76 | 106,655.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.84 | 132,821.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.91 | 100,861.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.39 | 86,777.8 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.66 | 89,575.0 |
| LUPIN LTD | 24,750.7 | 3.94 | 97,416.4 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.06 | 66,824.1 |
| ABBOTT INDIA LTD | 6,714.4 | 8.43 | 56,586.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.06x |
| Max industry PS | 15.98x |
| Median industry PS | 6.39x |
| Average industry PS | 6.62x |
You may also like the below Video Courses